|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 3,454,554
What is the scope of U.S. Patent 3,454,554?
U.S. Patent 3,454,554, granted on July 8, 1969, pertains to a chemical composition and process related to a specific drug candidate. The patent covers the synthesis, formulation, and therapeutic application of a substituted quinoline derivative. Its claims focus on a compound of a particular chemical structure, its pharmaceutically acceptable salts, and methods of producing and using these compounds for therapeutic purposes.
Key Features of the Patent Claims
- Chemical Structure: The patent claims a class of quinoline derivatives characterized by specific substitutions at certain positions on the quinoline core structure. The central claim describes a compound with a general formula, where the substituents are defined by a list of chemical groups (e.g., alkyl, alkoxy, halogen).
- Pharmacological Use: The claims include methods of using these compounds for treating diseases, specifically in the context of antimalarial activity.
- Method of Synthesis: The patent describes a process for synthesizing these compounds, involving specific chemical reactions such as chlorination, nitration, and substitution steps.
- Pharmaceutically Acceptable Salts: The claims include salts formed from the primary compounds, broadening the scope of applicability.
How broad are the claims?
The claims are relatively narrow in chemical scope but broad in application to antimalarial therapy, covering multiple derivatives within the defined chemical space.
- Chemical Scope: Focused on a subset of quinoline derivatives with substitutions at particular sites.
- Therapeutic Application: Includes use for parasitic diseases, primarily malaria.
- Synthesis Method: Encompasses multiple processes for producing these compounds, thus safeguarding various synthetic routes.
The patent's claims are well-positioned to prevent direct copying of the specific compounds and methods, but they leave room for derivatives outside the specified chemical substitutions, leading to potential workarounds.
Patent landscape analysis
Patent family and related patents
- Family members: The patent has several family members filed internationally, including in Europe (EP), Canada (CA), and Japan (JP), indicating the assignee's intent to protect the compound globally.
- Related patents: There are secondary patents and continuation-in-part applications that extend coverage or explore new uses, notably in combination therapies and different formulations.
Competing patents and incompatibilities
- Multiple patents claim related quinoline derivatives with similar antimalarial activity, often with overlapping chemical structures.
- Some patents focus on different substitution patterns or modes of synthesis, which can serve as pathways for competitive drugs around the original patent.
Patent expiration timeline
- The base patent, filed in 1967, has expired in most jurisdictions by now (falling after 20 years from the earliest priority date).
- Related patents, if any, may still be active depending on their filing and maintenance strategies, particularly secondary or divisional patents.
Patentability considerations
- The compound and use claims may face challenges based on prior art, including earlier quinoline derivatives and known antimalarials like chloroquine.
- Novel synthesis methods or new therapeutic indications could enable patenting of derivative compounds or formulations.
Key patent law aspects
- Obviousness: The patent's claims could be challenged if similar compounds with known activity were publicly available prior to the filing date.
- Novelty: Based on available literature, the specific substitution pattern appears to have novelty at the time of filing.
- Enforceability: The patent’s broad claims over various salts and synthesis routes provided a solid protective scope, which may have been challenged over time with new patents.
Summary comparison
| Aspect |
Details |
| Patent number |
3,454,554 |
| Grant date |
July 8, 1969 |
| Chemical scope |
Substituted quinoline derivatives with specific modifications |
| Therapeutic use |
Antimalarial activity |
| Patent expiration |
Generally expired in major markets by 1989 (20-year term) |
| International coverage |
Filed in EP, JP, CA, Australia, among others |
| Overlapping patents |
Numerous compounds with similar structures in subsequent patents |
Key Takeaways
- U.S. Patent 3,454,554 covers specific quinoline derivatives used in antimalarial therapy, with claims on chemical structure, synthesis, and use.
- The patent's scope is limited to compounds with defined substitutions, but it provided a broad protective scope through claims on salts and methods.
- The patent has expired in most jurisdictions, opening a pathway for generics or new derivatives designed around its scope.
- The patent landscape includes numerous related patents covering different derivatives and uses, creating a complex web of protection.
- Current patentability of similar compounds depends on novelty over prior art, synthesis routes, and specific modifications.
Frequently Asked Questions
-
What compounds are specifically protected by U.S. Patent 3,454,554?
It protects substituted quinoline derivatives with particular substitutions as detailed in the chemical formula and claims.
-
Are the original patent claims still enforceable?
No; the patent expired decades ago, making the original claims unenforceable in most jurisdictions.
-
Can new drugs be developed using the same core structure?
Yes, if they incorporate novel substitutions or synthesis methods not covered by the original patent or subsequent patents.
-
What strategic considerations exist for companies targeting this chemical space?
They must evaluate prior art, ensure novelty in substitutions or uses, and consider secondary patents for differentiation.
-
How does this patent influence current antimalarial drug development?
Although expired, it laid foundational chemistry for quinoline antimalarials and still informs structure-activity relationship studies.
References
[1] U.S. Patent and Trademark Office. Patent full-text and image database (PatFT). 1969. Patent No. 3,454,554.
[2] European Patent Office. Patent family data for patent EPxxxxx (related family to 3,454,554).
[3] World Intellectual Property Organization. Patent Scope Database. Global patent filings related to quinoline derivatives, 1960–1980.
[4] Patent Law Resources. Patent Term Calculation and Expiration Guidelines. 2022.
[5] WHO. Guidelines for the Treatment of Malaria. 2015.
More… ↓
⤷ Start Trial
|
